CRBN and plasma cell myeloma: The impact of the cellular redistribution on CRBN activity was supported by the recruitment of this protein in aggresomes and its cytoprotective role in cells exposed to proteasome inhibitors [36] as well as the requirement of nuclear import of CRBN for pomalidomide‐mediated anti‐myeloma activity [37].